Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance

Expert Rev Anticancer Ther. 2020 Feb;20(2):75-79. doi: 10.1080/14737140.2020.1717337. Epub 2020 Jan 27.

Authors

Khaleel I Al-Obaidy^{1

2}, Michal Chovanec³, Liang Cheng^{1

4}

Affiliations

¹ Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
² Department of Pathology, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
³ 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, 83310, Bratislava, Slovakia.
⁴ Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.

PMID: 31951790
DOI: 10.1080/14737140.2020.1717337

No abstract available

Keywords: Testis; biomarkers; molecular genetics; testicular germ cell tumors; the Cancer Genome Atlas (TCGA).

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / pharmacology*
Drug Resistance, Neoplasm
Humans
Male
Neoplasms, Germ Cell and Embryonal / drug therapy*
Neoplasms, Germ Cell and Embryonal / pathology
Testicular Neoplasms / drug therapy*
Testicular Neoplasms / pathology

Substances

Antineoplastic Agents

Supplementary concepts

Testicular Germ Cell Tumor